Familial hypocalciuric hypercalcemia historical perspective

Revision as of 14:48, 21 September 2017 by Ajay Gade (talk | contribs) (→‎Discovery)
Jump to navigation Jump to search

Familial hypocalciuric hypercalcemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial Hypocalciuric Hypercalcemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial hypocalciuric hypercalcemia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial hypocalciuric hypercalcemia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial hypocalciuric hypercalcemia historical perspective

CDC on Familial hypocalciuric hypercalcemia historical perspective

Familial hypocalciuric hypercalcemia historical perspective in the news

Blogs on Familial hypocalciuric hypercalcemia historical perspective

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Familial hypocalciuric hypercalcemia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Discovery

  • In the year 1966 FHH was first described by Jackson and Boonstra in a hypercalcemic patient presumed to have Hyperparathyroidism. He wasn't cured despite the removal of three and a half hyperplastic parathyroid glands. Subsequently, seventeen family members with hypercalcemia were identified in three generations[1][2].
  • A similar family was identified in the year 1972 by Foley Et al. The family members of both the families were asymptomatic and hypercalcemic which is very typical of FHH[2].
  • In 1990 ten cases of pancreatitis were reported in patients with family members of FHH[3].
  • In 1993 Brown Et al identified a bovine parathyroid cell Calcium sensing receptor cDNA by expression cloning in Xenopus laevis oocytes. The cDNA encoded a predicted 120-kD polypeptide containing a large extracellular domain and 7 membrane-spanning regions characteristic of G protein-coupled cell surface receptors. In addition to parathyroid tissue, It also identified the presence of CASR in regions of the kidney involved in Calcium regulated Calcium and Magnessium reabsorption[4].
  • In 1995 studies were conducted to characterize the mutations of Calcium sensing mutations in FHH and Neonatal hyperparathyroidism[5].

References

  1. "The relationship of hereditary hyperparathyroidism to endocrine adenomatosis - ScienceDirect".
  2. "Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid".
  3. "Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism".

Template:WH Template:WS